GB202307003D0 - Cannabinoid-based formulation - Google Patents
Cannabinoid-based formulationInfo
- Publication number
- GB202307003D0 GB202307003D0 GBGB2307003.0A GB202307003A GB202307003D0 GB 202307003 D0 GB202307003 D0 GB 202307003D0 GB 202307003 A GB202307003 A GB 202307003A GB 202307003 D0 GB202307003 D0 GB 202307003D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- cannabinoid
- based formulation
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 229930003827 cannabinoid Natural products 0.000 title 1
- 239000003557 cannabinoid Substances 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/04—Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate
- A61K35/06—Mineral oils, e.g. paraffinic oils or aromatic oils based on aromatic hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/348—Cannabaceae
- A61K36/3482—Cannabis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/0288—Applications, solvents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/35—Extraction with lipophilic solvents, e.g. Hexane or petrol ether
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Medical Informatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Physiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2307003.0A GB202307003D0 (en) | 2023-05-11 | 2023-05-11 | Cannabinoid-based formulation |
PCT/GB2024/051220 WO2024231692A1 (en) | 2023-05-11 | 2024-05-10 | Cannabinoid-based formulation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2307003.0A GB202307003D0 (en) | 2023-05-11 | 2023-05-11 | Cannabinoid-based formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202307003D0 true GB202307003D0 (en) | 2023-06-28 |
Family
ID=86872354
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2307003.0A Ceased GB202307003D0 (en) | 2023-05-11 | 2023-05-11 | Cannabinoid-based formulation |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB202307003D0 (en) |
WO (1) | WO2024231692A1 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2019008373A (en) * | 2017-01-14 | 2019-12-02 | Herbolea Biotech S R L | Enzyme-assisted lipid-based extraction and stabilization of phyto-cannabinoids and terpens and products obtained thereof. |
MX2023002687A (en) * | 2020-09-04 | 2023-05-03 | Herbolea Biotech S P A | Thc-free cannabinoid concentrate, method of obtaining the same and use thereof. |
WO2022254338A1 (en) * | 2021-06-04 | 2022-12-08 | Buzzelet Development And Technologies Ltd. | Compositions and methods for treating epilepsy and/or autism |
-
2023
- 2023-05-11 GB GBGB2307003.0A patent/GB202307003D0/en not_active Ceased
-
2024
- 2024-05-10 WO PCT/GB2024/051220 patent/WO2024231692A1/en unknown
Non-Patent Citations (4)
Title |
---|
"Remington's Pharmaceutical Sciences", 1990, MACK PUB. CO. EASTON |
BOOTHBOHLMANN, TERPENES IN CANNABIS SATIVA - FROM PLANT GENOME TO HUMANS, vol. 284, 2019, pages 67 - 72 |
LIEBLING ET AL.: "An Analysis of Over-the-Counter Cannabidiol Products in the United Kingdom", CANNABIS AND CANNABINOID RESEARCH, vol. 7, no. 2, 2022, pages 207 - 213 |
LUKAS VACLAVIK ET AL.: "Quantitation of Cannabinoids in Cannabis Dried Plant Materials, Concentrates, and Oils Using Liquid Chromatography-Diode Array Detection Technique with Optional Mass Spectrometric Detection: Single-Laboratory Validation Study, First Action 2018.11", JOURNAL OF AOAC INTERNATIONAL, vol. 102, no. 6, 1 November 2019 (2019-11-01), pages 1822 - 1833 |
Also Published As
Publication number | Publication date |
---|---|
WO2024231692A1 (en) | 2024-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL319149A (en) | Upadacitinib formulation | |
GB202007546D0 (en) | Formulation | |
IL307849A (en) | Sotorasib formulation | |
GB202318884D0 (en) | Formulation | |
GB202316857D0 (en) | Cannabinoid-based formulation | |
GB202312814D0 (en) | Formulation | |
GB202312220D0 (en) | Formulation | |
GB202311622D0 (en) | Formulation | |
GB202311439D0 (en) | Formulation | |
IL317857A (en) | Orellanine formulation | |
GB202308224D0 (en) | Formulation | |
GB202306990D0 (en) | Cannabinoid-based formulation | |
GB202307003D0 (en) | Cannabinoid-based formulation | |
GB202306995D0 (en) | Cannabinoid-based formulation | |
GB202307002D0 (en) | Cannabinoid-based formulation | |
GB202303663D0 (en) | Aerosolisable formulation | |
GB202218160D0 (en) | Formulation | |
GB202217857D0 (en) | Formulation | |
GB202217267D0 (en) | Aerosolisable formulation | |
GB202217148D0 (en) | Formulation | |
GB202216335D0 (en) | Formulation | |
GB202213663D0 (en) | Aerosolisable formulation | |
GB202211203D0 (en) | Formulation | |
GB202209298D0 (en) | Aerosolisable formulation | |
GB202211231D0 (en) | Novel formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |